{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:47:30Z","timestamp":1793202450719,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.idc.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T12:14:56Z","timestamp":1555503296000},"page":"399-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient"],"prefix":"10.1016","volume":"33","author":[{"given":"Elizabeth Ann","family":"Misch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2019.02.011_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1702503","article-title":"Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies","volume":"26","author":"\u00c7elebi","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J\u00a0Infect Chemother"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib3","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood.V95.12.3683","article-title":"Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants","volume":"95","author":"Kulkarni","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib5","first-page":"907","article-title":"Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation","volume":"15","author":"Demirer","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.idc.2019.02.011_bib7","series-title":"The EBMT handbook on haematopoietic stem cell transplantation","first-page":"196","article-title":"Infections after HSCT","author":"Rovira","year":"2012"},{"key":"10.1016\/j.idc.2019.02.011_bib8","series-title":"Infectious complications of neoplastic disease, controversies in management","first-page":"19","article-title":"Neutropenia, fever, and infection","author":"Brown","year":"1985"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/bmt.2017.14","article-title":"Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis","volume":"52","author":"Dandoy","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/ciw113","article-title":"Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009-2012","volume":"62","author":"See","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajic.2014.11.014","article-title":"National Healthcare Safety Network report, data summary for 2013, device-associated module","volume":"43","author":"Dudeck","year":"2015","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.transproceed.2017.03.081","article-title":"Complications and multidrug-resistant bacteria in patients with hematopoietic stem cell transplantation in the first 12\u00a0months after transplant","volume":"49","author":"C\u00e9sar-Arce","year":"2017","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib13","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the european bone marrow transplantation group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00277-013-1872-4","article-title":"Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients","volume":"93","author":"Pi\u00f1ana","year":"2014","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1700621","article-title":"Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation","volume":"19","author":"Kolbe","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.idc.2019.02.011_bib16","series-title":"Clinical approach to infection in the compromised host","first-page":"5","article-title":"Epidemiology and prevention of infection in the compromised host","author":"Wade","year":"1988"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01700277","article-title":"Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy","volume":"69","author":"Link","year":"1994","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group","volume":"120","author":"De Pauw","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1995.13.1.165","article-title":"Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem","volume":"13","author":"Freifeld","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/bmt.2014.37","article-title":"Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients","volume":"49","author":"Gudiol","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.idc.2019.02.011_bib21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","article-title":"Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation","volume":"22","author":"Ballen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib22","doi-asserted-by":"crossref","first-page":"ofx050","DOI":"10.1093\/ofid\/ofx050","article-title":"Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study","volume":"4","author":"Schuster","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jmii.2016.02.003","article-title":"Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence","volume":"51","author":"Wang","year":"2018","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib24","doi-asserted-by":"crossref","first-page":"179e1-10","DOI":"10.1016\/j.cmi.2015.10.017","article-title":"Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study","volume":"22","author":"Styczynski","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","article-title":"Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors","volume":"22","author":"Young","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cmi.2017.03.020","article-title":"Secular trends of bloodstream infections during neutropenia in 15,181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS)","volume":"23","author":"Weisser","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib27","first-page":"321","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bbmt.2014.12.038","article-title":"Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen","volume":"21","author":"Sanz","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/tid.12175","article-title":"Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations","volume":"16","author":"Blennow","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"45","key":"10.1016\/j.idc.2019.02.011_bib30","doi-asserted-by":"crossref","first-page":"e1931","DOI":"10.1097\/MD.0000000000001931","article-title":"Prevalence of resistant gram-negative bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: a single center retrospective cohort study","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/tid.12345","article-title":"Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Kikuchi","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2012.08.012","article-title":"Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Srinivasan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-016-2828-2","article-title":"Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG","volume":"96","author":"Zheng","year":"2017","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib35","doi-asserted-by":"crossref","first-page":"e12629","DOI":"10.1111\/tid.12629","article-title":"Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation","volume":"19","author":"Slade","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.bbmt.2015.06.017","article-title":"Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation","volume":"21","author":"Satlin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/tid.12165","article-title":"Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience","volume":"16","author":"Srinivasan","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib38","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian Prospective Multicenter Survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5858\/2005-129-366-PCABMT","article-title":"Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center","volume":"129","author":"Roychowdhury","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib41","doi-asserted-by":"crossref","first-page":"e12627","DOI":"10.1111\/tid.12627","article-title":"Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient","volume":"19","author":"Baluch","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/tid.12201","article-title":"Cutaneous legionellosis: case report and review of the medical literature","volume":"16","author":"Padrnos","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/513654","article-title":"Nocardiosis after bone marrow transplantation: a retrospective study","volume":"24","author":"Van Burik","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/tid.12499","article-title":"Nocardiosis following hematopoietic stem cell transplantation","volume":"18","author":"Shannon","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bmt.2014.231","article-title":"Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy","volume":"50","author":"Girmenia","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib46","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/bmt.2016.181","article-title":"Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study","volume":"51","author":"van Veen","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib47","doi-asserted-by":"crossref","first-page":"e12745","DOI":"10.1111\/tid.12745","article-title":"Legionnaires' disease in transplant recipients: a 15-year retrospective study in a tertiary referral center","volume":"19","author":"Sivagnanam","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.patbio.2014.04.001","article-title":"Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor","volume":"62","author":"Mansi","year":"2014","journal-title":"Pathol Biol (Paris)"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MPH.0b013e31819ed274","article-title":"Nontuberculous mycobacteria infections in immunocompromised patients: single institution experience","volume":"31","author":"Wei","year":"2009","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbmt.2017.09.015","article-title":"Incidence and risk factors for nontuberculous mycobacterial infection after allogeneic hematopoietic cell transplantation","volume":"24","author":"Beswick","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.idc.2019.02.011_bib51","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.transproceed.2017.03.073","article-title":"Concurrent hepatic tuberculosis and hepatic graft-versus-host disease in an allogeneic hematopoietic stem cell transplant recipient: a case report","volume":"49","author":"Zhao","year":"2017","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5588\/ijtld.14.0301","article-title":"Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study","volume":"19","author":"Fan","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0000000000000404","article-title":"Nocardia infections in solid organ and hematopoietic stem cell transplant recipients","volume":"30","author":"Coussement","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies","volume":"12","author":"N\u00f8rgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib55","first-page":"239","article-title":"Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns","volume":"18","author":"Funada","year":"1988","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2169\/internalmedicine.37.1014","article-title":"Changes in the incidence and etiological patterns of bacteremia associated with acute leukemia over a 25-year period","volume":"37","author":"Funada","year":"1998","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF00157395","article-title":"Nosocomial outbreak of severe Pseudomonas aeruginosa infections in haematological patients","volume":"9","author":"Grigis","year":"1993","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/520247","article-title":"Pseudomonas aeruginosa - still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center","volume":"29","author":"Rolston","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2019.02.011_bib59","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1093\/clinids\/17.Supplement_2.S322","article-title":"The changing epidemiology of infections at cancer hospitals","volume":"17","author":"Koll","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib60","first-page":"34","article-title":"Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer)","volume":"1","author":"Coullioud","year":"1993","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10096-006-0173-4","article-title":"Changing trends in etiology of bacteremia in patients with cancer","volume":"25","author":"Safdar","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.blre.2008.10.003","article-title":"Bloodstream infections in haematology: risks and new challenges for prevention","volume":"23","author":"Worth","year":"2009","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01695660","article-title":"Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution","volume":"15","author":"Gonzalez-Barca","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2019.02.011_bib64","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl C","key":"10.1016\/j.idc.2019.02.011_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jac\/21.suppl_C.157","article-title":"Septicaemia due to gram-positive cocci in cancer patients","volume":"21","author":"Del Favero","year":"1988","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0002-9343(87)90007-6","article-title":"Bacteremia and fungemia in patients with neoplastic disease","volume":"82","author":"Whimbey","year":"1987","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.idc.2019.02.011_bib67","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","article-title":"Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients","volume":"33","author":"Collin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib68","doi-asserted-by":"crossref","first-page":"e2015045","DOI":"10.4084\/mjhid.2015.045","article-title":"Bacterial infections in hematopoietic stem cell transplant recipients","volume":"7","author":"Balletto","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib69","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0019-509X.200647","article-title":"Epidemiology and resistance pattern of bacterial isolates among cancer patients in a Tertiary Care Oncology Centre in North India","volume":"53","author":"Batra","year":"2016","journal-title":"Indian J Cancer"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib70","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/resp.12848","article-title":"Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients","volume":"21","author":"Gudiol","year":"2016","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib71","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/cid\/cix232","article-title":"Prediction of bloodstream infection due to vancomycin-resistant Enterococcus in patients undergoing leukemia induction or hematopoietic stem-cell transplantation","volume":"64","author":"Webb","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib72","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1017\/S0950268810000919","article-title":"Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.idc.2019.02.011_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","article-title":"Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis","volume":"24","author":"van Aalst","year":"2018","journal-title":"Travel Med Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/tid.12268","article-title":"Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Torda","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib75","series-title":"Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae","author":"CDC","year":"2016"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/md.0b013e31803eb176","article-title":"Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005","volume":"86","author":"Youssef","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.idc.2019.02.011_bib77","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1705964","article-title":"Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance","volume":"41","author":"Kumar","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib78","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib79","doi-asserted-by":"crossref","first-page":"e0153106","DOI":"10.1371\/journal.pone.0153106","article-title":"Disease burden of 32 infectious diseases in the Netherlands, 2007-2011","volume":"11","author":"van Lier","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib80","doi-asserted-by":"crossref","first-page":"e0140185","DOI":"10.1371\/journal.pone.0140185","article-title":"Streptococcus pneumoniae serotypes and mortality in adults and adolescents in South Africa: analysis of National Surveillance Data, 2003 - 2008","volume":"10","author":"Cohen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnci.2013.12.001","article-title":"Source, pattern and antibiotic resistance of blood stream infections in hematopoietic stem cell transplant recipients","volume":"26","author":"El-Mahallawy","year":"2014","journal-title":"J\u00a0Egypt Natl Canc Inst"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib82","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4103\/0019-509X.204766","article-title":"Spectrum of bacteremia in posthematopoietic stem cell transplant patients from an Indian center","volume":"53","author":"Ghafur","year":"2016","journal-title":"Indian J Cancer"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","article-title":"Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant recipients","volume":"40","author":"Mikulska","year":"2012","journal-title":"Infection"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib84","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3109\/10428194.2014.896007","article-title":"The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients","volume":"55","author":"Satlin","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib85","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbmt.2017.01.073","article-title":"A\u00a0multicenter study of bacterial blood stream infections in pediatric allogeneic hematopoietic cell transplantation recipients: the role of acute gastrointestinal graft-versus-host disease","volume":"23","author":"Satwani","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib86","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0609.2007.00911.x","article-title":"Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk","volume":"79","author":"Worth","year":"2007","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib87","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3062.2010.00544.x","article-title":"Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients","volume":"12","author":"Mikulska","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib88","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/342904","article-title":"Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci","volume":"35","author":"Zaas","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib89","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/516112","article-title":"Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia","volume":"25","author":"Roghmann","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib90","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1086\/503675","article-title":"Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer","volume":"42","author":"Matar","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbmt.2007.01.078","article-title":"Colonization, bloodstream infection, and mortality caused by vancomycin-resistant Enterococcus early after allogeneic hematopoietic stem cell transplant","volume":"13","author":"Weinstock","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib92","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/cis550","article-title":"Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Vydra","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib93","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/bmt.2014.150","article-title":"Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation","volume":"49","author":"Tavadze","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib94","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/tid.12612","article-title":"Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia","volume":"18","author":"Hefazi","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib95","article-title":"Impact of empiric treatment for vancomycin-resistant Enterococcus in colonized patients early after allogeneic hematopoietic stem cell transplantation","author":"Kamboj","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.idc.2019.02.011_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijid.2015.02.001","article-title":"Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp","volume":"33","author":"Lisboa","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib97","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jac\/dkx350","article-title":"Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study","volume":"73","author":"Seas","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods","volume":"39","author":"Stefani","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciy399","article-title":"National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010\u20132014","volume":"68","author":"Klein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13756-017-0193-0","article-title":"The incidence of MRSA infections in the United States: is a more comprehensive tracking system needed?","volume":"6","author":"Kavanagh","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idc.2019.02.011_bib101","series-title":"Antimicrobial resistance surveillance in Europe 2017: annual report of the European antimicrobial resistance surveillance network (EARS-Net)","year":"2017"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajic.2014.10.010","article-title":"Evaluation of routine pretransplantation screening for methicillin-resistant Staphylococcus aureus in hematopoietic cell transplant recipients","volume":"43","author":"Miles-Jay","year":"2015","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib103","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5045\/br.2016.51.2.102","article-title":"Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation","volume":"51","author":"Stoma","year":"2016","journal-title":"Blood Res"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12185-016-2113-0","article-title":"Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis","volume":"105","author":"Choeyprasert","year":"2017","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1198-743x.2001.00230.x","article-title":"Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America","volume":"7","author":"Diekema","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib106","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(94)90009-4","article-title":"Bacteremia due to viridans streptococci in neutropenic patients: a review","volume":"97","author":"Bochud","year":"1994","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib107","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","article-title":"Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors","volume":"14","author":"Elting","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/cid\/ciu264","article-title":"Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?","volume":"59","author":"Freifeld","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib109","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/317460","article-title":"Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer","volume":"31","author":"Marron","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib110","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/clinids\/20.5.1169","article-title":"Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer","volume":"20","author":"Carratala","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.011_bib111","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/AAC.39.10.2243","article-title":"In\u00a0vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood","volume":"39","author":"Alcaide","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib112","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/47.1.87","article-title":"High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients","volume":"47","author":"Marron","year":"2001","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib113","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.idc.2019.02.011_bib114","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1056\/NEJM198810203191604","article-title":"Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer","volume":"319","author":"Shenep","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib116","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/598622","article-title":"Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons","volume":"29","author":"Feld","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib117","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciu260","article-title":"Development and validation of a clinical model to predict the presence of \u03b2-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients","volume":"59","author":"Shelburne","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib118","series-title":"Performance standards for antimicrobial susceptibility testing: 24th informational supplement M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.idc.2019.02.011_bib119","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12879-016-1692-y","article-title":"Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital","volume":"16","author":"Kimura","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1471-2334-13-273","article-title":"Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children","volume":"13","author":"Han","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"14","key":"10.1016\/j.idc.2019.02.011_bib121","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib122","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","article-title":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"96","author":"Heinz","year":"2017","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.idc.2019.02.011_bib123","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00277-014-2086-0","article-title":"Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)","volume":"93","author":"Penack","year":"2014","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib124","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.idc.2019.02.011_bib125","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib126","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2011.26.2.220","article-title":"Evidence-based guidelines for empirical therapy of neutropenic fever in Korea","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib127","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":"High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib128","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000114817.58194.BF","article-title":"Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality","volume":"32","author":"Lujan","year":"2004","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0002-9343(02)01162-2","article-title":"The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections","volume":"113","author":"Pallares","year":"2002","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.idc.2019.02.011_bib131","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1469-0691.2005.01260.x","article-title":"Nosocomial bloodstream infections caused by Streptococcus pneumoniae","volume":"11","author":"Bouza","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2019.02.011_bib132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.md.0000180045.26909.29","article-title":"Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002)","volume":"84","author":"Kumashi","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib133","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib134","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00089-17","article-title":"Emerging technologies for molecular diagnosis of sepsis","volume":"31","author":"Sinha","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/EuJMI.4.2014.1.1","article-title":"Molecular diagnosis of sepsis: New aspects and recent developments","volume":"4","author":"Liesenfeld","year":"2014","journal-title":"Eur J Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.idc.2019.02.011_bib136","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/myc.12662","volume":"60","author":"Elges","year":"2017","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib137","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/cid\/cix743","article-title":"Demise of polymerase chain reaction\/electrospray ionization-mass spectrometry as an infectious diseases diagnostic tool","volume":"66","author":"\u00d6zenci","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib139","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcp.12310","article-title":"The prevention and management of infections due to multidrug resistant organisms in haematology patients","volume":"79","author":"Trubiano","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"23","key":"10.1016\/j.idc.2019.02.011_bib140","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/adhm.201600757","article-title":"Simple and specific grafting of antibacterial peptides on silicone catheters","volume":"5","author":"Pinese","year":"2016","journal-title":"Adv Healthc Mater"},{"issue":"35","key":"10.1016\/j.idc.2019.02.011_bib141","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1200\/JCO.2008.16.4681","article-title":"Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia","volume":"26","author":"Gardner","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.idc.2019.02.011_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1705040","article-title":"Isolation in the allogeneic transplant environment: how protective is it?","volume":"36","author":"Hayes-Lattin","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10096-007-0397-y","article-title":"Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials","volume":"27","author":"Imran","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2019.02.011_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcsup.2007.06.001","article-title":"Guidelines from the first European conference on infections in leukaemia: ECIL1","volume":"5","author":"Cordonnier","year":"2007","journal-title":"Eur J Cancer Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2019.02.011_bib145","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.bjc.6605270","article-title":"Prevention of febrile neutropenia: use of prophylactic antibiotics","volume":"101","author":"Cullen","year":"2009","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.idc.2019.02.011_bib146","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"1b","key":"10.1016\/j.idc.2019.02.011_bib147","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","article-title":"Use of antibacterial prophylaxis for patients with neutropenia","volume":"41","author":"Slavin","year":"2011","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.idc.2019.02.011_bib148","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10096-010-1093-x","article-title":"Risk factors for, and clinical relevance of, faecal extended-spectrum \u03b2-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies","volume":"30","author":"Arnan","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.011_bib149","first-page":"143","article-title":"Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle","volume":"40","author":"De Rosa","year":"2017","journal-title":"New Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2019.02.011_bib150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2019.02.011_bib151","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.idc.2019.02.011_bib152","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-016-0301-4","article-title":"Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection","volume":"8","author":"Montassier","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.idc.2019.02.011_bib153","series-title":"Antibiotics currently in global clinical development (updated Sept 2018)","year":"2018"},{"issue":"9","key":"10.1016\/j.idc.2019.02.011_bib154","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1128\/AAC.02955-14","article-title":"Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16","volume":"58","author":"Mensa","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:13:24Z","timestamp":1760195604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552019300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0891552019300145"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.011","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}